Protara Therapeutics, Inc. Common Stock (TARA) is a publicly traded Healthcare sector company. As of October 15, 2026, TARA trades at $2.51 with a market cap of $154.83M and a P/E ratio of -1.91. TARA moved -0.20% today. Year to date, TARA is -53.90%; over the trailing twelve months it is -53.73%. Its 52-week range spans $2.47 to $7.82. Analyst consensus is strong buy with an average price target of $24.00. Rallies surfaces TARA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks TARA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $2.51 |
| Market Cap | $154.83M |
| P/E Ratio | -1.91 |
| EPS | $-1.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.82 |
| 52-Week Low | $2.47 |
| Volume | 53.22K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-57.44M |
| Gross Margin | 0.00% |
3 analysts cover TARA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.00.